National Health Investors, Inc. (NHI) Stock Price & How to Invest

National Health Investors is a real estate investment trust based in Murfreesboro, Tennessee that owns senior housing, independent living, assisted living, memory care and medical office properties across the United States. Historically it was a triple-net lease landlord: it bought buildings, leased them to operators such as National HealthCare Corporation, Bickford Senior Living and Senior Living Communities, and collected contractual rent with the operator carrying staffing and occupancy risk. Over the past two years the company has been adding a Senior Housing Operating Portfolio (SHOP) segment, where it takes the property-level revenue and expenses directly instead of a fixed rent check. On a pro forma basis SHOP represents roughly 22% of total investments and about 14% of annualized net operating income, and management has been steering new capital toward it.

The defining event of 2026 is the agreed sale of 32 skilled nursing facilities and three independent living communities back to National HealthCare Corporation for $560 million, which closed on July 1. That transaction removes the largest single tenant relationship and a large block of government-reimbursed skilled nursing exposure, replacing it with cash and a narrower private-pay senior housing footprint. It also cut reported earnings power in the near term: full year 2026 NAREIT and normalized FFO per diluted share guidance moved from a range of ~$4.94 to ~$4.99 down to ~$4.74 to ~$4.79, a mechanical result of selling income-producing assets before the proceeds are fully redeployed. The offset is a balance sheet with pro forma net debt to EBITDA around ~2.3x, unusually low for a REIT, plus an investment pipeline management has sized near $560 million, so the redeployment pace is the variable that decides whether the dilution is temporary or lasting.

The clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold. Concentration remains real even after the NHC exit, since a handful of operators including Bickford, Senior Living Communities and the National Health Corporation relationship still account for a large share of revenue, and an operator in distress can force a rent reset or a transition. Moving toward SHOP structurally increases earnings volatility, because labor inflation, insurance costs and occupancy swings hit NHI directly rather than being absorbed by a tenant. As a REIT with a payout obligation, NHI is also sensitive to long-term interest rates on two fronts: higher rates raise refinancing and acquisition hurdle costs, and they compete directly with the dividend yield for income-oriented capital. Finally, senior housing assets face physical and reimbursement risk in the remaining non-private-pay exposure, where policy changes to Medicaid or Medicare rates can pressure the operators that pay the rent.

8 analysts publish price targets on NHI, averaging $82.88 against a $75.30 price as of August 2026, or +10.1%. The published targets run from $74.00 to $91.00, a narrow spread, and the ratings split 5 buy, 3 hold, 0 sell. Over the last six months there have been 2 raises and 6 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full NHI forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on National Health Investors, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Redeploying the NHC sale proceeds. The $560 million from the skilled nursing sale is the single biggest swing factor in the next several quarters. The most optimistic published target, $91.00, assumes this works close to its best case.

The case against. The clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold. The most pessimistic target, $74.00, is roughly what NHI is worth if this bites instead.

Read the full bull and bear case on NHI, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see National Health Investors, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$376 million
• Normalized FFO per share (2026 guidance): ~$4.74 to ~$4.79
• Dividend yield: ~4.3% (~$0.92 quarterly, ~$3.68 annualized)
• Payout ratio (on normalized FFO): ~77%
• Price to FFO: ~18x
• Net debt to EBITDA (pro forma): ~2.3x

REITs are valued on funds from operations rather than GAAP earnings, because real estate depreciation is a large non-cash charge that understates cash generation. At roughly 18 times the midpoint of 2026 normalized FFO guidance, NHI trades in the range typical of healthcare REITs with a senior housing tilt, with the caveat that the guidance itself was lowered on the NHC sale rather than on operating weakness. The ~2.3x pro forma net debt to EBITDA is the number that stands out against the sector, where mid-to-high single-digit turns are more common.

Other names that sit close to NHI: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get NHI exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so NHI sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NHI fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

NHI is a mid-cap senior housing landlord in the middle of a deliberate swap of stable skilled nursing rent for higher-beta private-pay operating exposure, funded by a very low-leverage balance sheet.

Whether NHI is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NHI a buy or a sell?, and where the stock could go from here in the NHI stock forecast.

For income investors, whether NHI pays a dividend and how the payout looks is covered in does NHI pay a dividend? And to weigh NHI against a peer, read the full side-by-side comparisons: NHI vs WELL and NHI vs VTR.